INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,184,000 | -0.9% | 144,713 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $2,203,000 | -71.4% | 144,534 | -27.2% | 0.00% | -70.0% |
| Q2 2016 | $7,712,000 | +65.5% | 198,655 | +18.5% | 0.01% | +66.7% |
| Q1 2016 | $4,659,000 | -44.5% | 167,595 | +7.3% | 0.01% | -45.5% |
| Q4 2015 | $8,399,000 | +44.0% | 156,141 | +7.2% | 0.01% | +37.5% |
| Q3 2015 | $5,831,000 | +51.3% | 145,639 | +20.8% | 0.01% | +60.0% |
| Q2 2015 | $3,853,000 | +27.7% | 120,602 | -4.5% | 0.01% | +25.0% |
| Q1 2015 | $3,017,000 | +56.2% | 126,321 | +15.5% | 0.00% | +33.3% |
| Q4 2014 | $1,931,000 | +28.1% | 109,390 | -0.5% | 0.00% | +50.0% |
| Q3 2014 | $1,507,000 | -17.9% | 109,955 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,836,000 | – | 108,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |